Assessment Causality in Associations Between Serum Uric Acid and Risk of Schizophrenia: A Two-Sample Bidirectional Mendelian Randomization Study

References

• van Dongen J, Boomsma DI. The evolutionary paradox and the missing heritability of schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2013;162B(2):122–136. doi:10.1002/ajmg.b.3213523355297
   PubMed Web of Science ®Google Scholar
• Yao JK, Dougherty GG Jr, Reddy RD, et al. Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naive patients with schizophrenia. PLoS One. 2010;5(3):e9508. doi:10.1371/journal.pone.000950820209081
   PubMed Web of Science ®Google Scholar
• Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res. 2011;131(1–3):101–104. doi:10.1016/j.schres.2011.06.00821741216
   PubMed Web of Science ®Google Scholar
• Laursen TM, Munk-Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatr. 2012;25(2):83–88. doi:10.1097/YCO.0b013e32835035ca
   PubMed Web of Science ®Google Scholar
• Yao JK, Reddy R, van Kammen DP. Reduced level of plasma antioxidant uric acid in schizophrenia. Psychiatry Res. 1998;80(1):29–39. doi:10.1016/S0165-1781(98)00051-19727961
   PubMed Web of Science ®Google Scholar
• Yao JK, Reddy R, van Kammen DP. Abnormal age-related changes of plasma antioxidant proteins in schizophrenia. Psychiatry Res. 2000;97(2–3):137–151. doi:10.1016/S0165-1781(00)00230-411166086
   PubMed Web of Science ®Google Scholar
• Reddy R, Keshavan M, Yao JK. Reduced plasma antioxidants in first-episode patients with schizophrenia. Schizophr Res. 2003;62(3):205–212. doi:10.1016/S0920-9964(02)00407-312837516
   PubMed Web of Science ®Google Scholar
• Pingmuangkaew P, Tangvarasittichai O, Tangvarasittichai S. Association of elevated serum uric acid with the components of metabolic syndrome and oxidative stress in abdominal obesity subjects. Indian J Clin Biochem. 2015;30(3):286–292. doi:10.1007/s12291-014-0462-026089614
   PubMedGoogle Scholar
• Ishizaka Y, Yamakado M, Toda A, Tani M, Ishizaka N. Relationship between serum uric acid and serum oxidative stress markers in the Japanese general population. Nephron Clin Pract. 2014;128(1–2):49–56. doi:10.1159/00036245625342428
   PubMedGoogle Scholar
• Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78(11):6858–6862. doi:10.1073/pnas.78.11.68586947260
   PubMed Web of Science ®Google Scholar
• Li X, Meng X, Timofeeva M, et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ. 2017;357:j2376. doi:10.1136/bmj.j237628592419
   PubMed Web of Science ®Google Scholar
• Flatow J, Buckley P, Miller BJ. Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry. 2013;74(6):400–409. doi:10.1016/j.biopsych.2013.03.01823683390
   PubMed Web of Science ®Google Scholar
• Pae C-U, Paik I-H, Lee C, Lee S-J, Kim J-J, Lee C-U. Decreased plasma antioxidants in schizophrenia. Neuropsychobiology. 2004;50(1):54–56. doi:10.1159/00007794215179021
   PubMed Web of Science ®Google Scholar
• Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60(12):1187–1192. doi:10.1001/archpsyc.60.12.118714662550
   PubMed Web of Science ®Google Scholar
• Lichtenstein P, Yip BH, Bjork C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373(9659):234–239. doi:10.1016/S0140-6736(09)60072-619150704
   PubMed Web of Science ®Google Scholar
• Schizophrenia Working Group of the Psychiatric Genomics C. SBiological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421–427. doi:10.1038/nature1359525056061
   PubMed Web of Science ®Google Scholar
• Kalousdian S, Fabsitz R, Havlik R, Christian J, Rosenman R. Heritability of clinical chemistries in an older twin cohort: the NHLBI Twin Study. Genet Epidemiol. 1987;4(1):1–11. doi:10.1002/gepi.13700401023569874
   PubMed Web of Science ®Google Scholar
• Rice T, Vogler GP, Perry TS, Laskarzewski PM, Province MA, Rao DC. Heterogeneity in the familial aggregation of fasting serum uric acid level in five North American populations: the lipid research clinics family study. Am J Med Genet. 1990;36(2):219–225. doi:10.1002/(ISSN)1096-86282368810
   PubMed Web of Science ®Google Scholar
• Wilk JB, Djousse L, Borecki I, et al. Segregation analysis of serum uric acid in the NHLBI family heart study. Hum Genet. 2000;106(3):355–359. doi:10.1007/s00439000024310798367
   PubMed Web of Science ®Google Scholar
• Kottgen A, Albrecht E, Teumer A, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45(2):145–154. doi:10.1038/ng.250023263486
   PubMed Web of Science ®Google Scholar
• Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004;33(1):30–42. doi:10.1093/ije/dyh13215075143
   PubMed Web of Science ®Google Scholar
• Sheehan NA, VD P, Burton R, Tobin MD. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 2008;5(8):1205–1210. doi:10.1371/journal.pmed.0050177
   Web of Science ®Google Scholar
• Bochud M, Rousson V. Usefulness of Mendelian randomization in observational epidemiology. Int J Environ Res Public Health. 2010;7(3):711–728. doi:10.3390/ijerph703071120616999
   PubMed Web of Science ®Google Scholar
• Smith GD, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1–22. doi:10.1093/ije/dyg07012689998
   PubMed Web of Science ®Google Scholar
• Qian Y, Ye D, Wu DJ, et al. Role of cigarette smoking in the development of ischemic stroke and its subtypes: a Mendelian randomization study. Clin Epidemiol. 2019;11:725–731. doi:10.2147/CLEP.S21593331616189
   PubMed Web of Science ®Google Scholar
• Gao X, Meng LX, Ma KL, et al. The bidirectional causal relationships of insomnia with five major psychiatric disorders: a Mendelian randomization study. Eur Psychiatry. 2019;60:79–85. doi:10.1016/j.eurpsy.2019.05.00431234011
   PubMed Web of Science ®Google Scholar
• Polimanti R, Gelernter J, Stein DJ. Genetically determined schizophrenia is not associated with impaired glucose homeostasis. Schizophr Res. 2018;195:286–289. doi:10.1016/j.schres.2017.10.03329092750
   PubMed Web of Science ®Google Scholar
• Hartwig FP, Borges MC, Horta BL, Bowden J, Davey Smith G. Inflammatory biomarkers and risk of schizophrenia: a 2-sample Mendelian randomization study. JAMA Psychiatry. 2017;74(12):1226–1233. doi:10.1001/jamapsychiatry.2017.319129094161
   PubMed Web of Science ®Google Scholar
• Noyce AJ, Kia DA, Hemani G, et al. Estimating the causal influence of body mass index on risk of parkinson disease: a Mendelian randomisation study. PLoS Med. 2017;14(6):e1002314. doi:10.1371/journal.pmed.100231428609445
   PubMed Web of Science ®Google Scholar
• Xu L, Borges MC, Hemani G, Lawlor DA. The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study. Diabetologia. 2017;60(11):2210–2220. doi:10.1007/s00125-017-4396-y28889241
   PubMed Web of Science ®Google Scholar
• Zhang B, Shu X-O, Delahanty RJ, et al. Height and breast cancer risk: evidence from prospective studies and Mendelian randomization. J Natl Cancer Inst. 2015;107:11. doi:10.1093/jnci/djv219
   Google Scholar
• Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet. 2005;365(9455):224–232. doi:10.1016/S0140-6736(05)70152-515652605
   PubMed Web of Science ®Google Scholar
• Hemani G, Zheng J, Elsworth B, et al. The MR-base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408. doi:10.7554/eLife.3440829846171
   PubMed Web of Science ®Google Scholar
• Keenan T, Zhao W, Rasheed A, et al. Causal assessment of serum urate levels in cardiometabolic diseases through a Mendelian randomization study. J Am Coll Cardiol. 2016;67(4):407–416. doi:10.1016/j.jacc.2015.10.08626821629
   PubMed Web of Science ®Google Scholar
• Yuan H, Yang W. Genetically determined serum uric acid and alzheimer’s disease risk. J Alzheimers Dis. 2018;65(4):1259–1265. doi:10.3233/JAD-18053830149453
   PubMed Web of Science ®Google Scholar
• Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, Inoue M. Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation. 2002;105(10):1155–1157. doi:10.1161/hc1002.10593511889006
   PubMed Web of Science ®Google Scholar
• de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76(2–3):135–157. doi:10.1016/j.schres.2005.02.01015949648
   PubMed Web of Science ®Google Scholar
• Kamat MA, Blackshaw JA, Young R, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35(22):4851–4853. doi:10.1093/bioinformatics/btz46931233103
   PubMed Web of Science ®Google Scholar
• Buniello A, MacArthur JAL, Cerezo M, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1):D1005–D1012. doi:10.1093/nar/gky112030445434
   PubMed Web of Science ®Google Scholar
• Hartwig FP, Davies NM, Hemani G, Davey Smith G. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int J Epidemiol. 2016;45(6):1717–1726. doi:10.1093/ije/dyx02828338968
   PubMed Web of Science ®Google Scholar
• Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658–665. doi:10.1002/gepi.2175824114802
   PubMed Web of Science ®Google Scholar
• Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377–389. doi:10.1007/s10654-017-0255-x28527048
   PubMed Web of Science ®Google Scholar
• Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–525. doi:10.1093/ije/dyv08026050253
   PubMed Web of Science ®Google Scholar
• Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–314. doi:10.1002/gepi.2016.40.issue-427061298
   PubMed Web of Science ®Google Scholar
• Cole TJ. Sympercents: symmetric percentage differences on the 100 log(e) scale simplify the presentation of log transformed data. Stat Med. 2000;19(22):3109–3125. doi:10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F11113946
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ. 1997;315(7121):1533–1537. doi:10.1136/bmj.315.7121.15339432252
   PubMed Web of Science ®Google Scholar
• Greco MFD, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34(21):2926–2940. doi:10.1002/sim.v34.2125950993
   PubMed Web of Science ®Google Scholar
• Prins BP, Abbasi A, Wong A, et al. Investigating the causal relationship of C-reactive protein with 32 complex somatic and psychiatric outcomes: a large-scale cross-consortium Mendelian randomization study. PLoS Med. 2016;13(6):e1001976. doi:10.1371/journal.pmed.100197627327646
   PubMed Web of Science ®Google Scholar
• Brion M-JA, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497–1501. doi:10.1093/ije/dyt17924159078
   PubMed Web of Science ®Google Scholar
• Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40(3):740–752. doi:10.1093/ije/dyq15120813862
   PubMed Web of Science ®Google Scholar
• Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample Mendelian randomization. Genet Epidemiol. 2016;40(7):597–608. doi:10.1002/gepi.2199827625185
   PubMed Web of Science ®Google Scholar
• Dastani Z, Hivert MF, Timpson N, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012;8(3):e1002607. doi:10.1371/journal.pgen.100260722479202
   PubMed Web of Science ®Google Scholar
• Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012;380(9841):572–580. doi:10.1016/S0140-6736(12)60312-222607825
   PubMed Web of Science ®Google Scholar
• Fujimaki K, Toki S, Yamashita H, Oyamada T, Yamawaki S. Predictors of negative symptoms in the chronic phase of schizophrenia: a cross-sectional study. Psychiatry Res. 2018;262:600–608. doi:10.1016/j.psychres.2017.09.05128965809
   PubMed Web of Science ®Google Scholar
• Gultekin BK, Kesebir S, Kabak SG, Ergun FF, Tatlidil Yaylaci E. Are uric acid levels different from healthy subjects in bipolar affective disorder and schizophrenia?: Relationship between clinical improvement and episode severity in male patients. Noro Psikiyatr Ars. 2014;51(3):229–232. doi:10.4274/npa.y682728360631
   PubMedGoogle Scholar
• Dadheech G, Sharma P, Gautam S. Oxidative stress-induced response of some endogenous antioxidants in schizophrenia. Indian J Clin Biochem. 2012;27(3):278–283. doi:10.1007/s12291-012-0193-z26405388
   PubMedGoogle Scholar
• Akanji AO, Ohaeri JU, Al-Shammri SA, Fatania HR. Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects. Clin Chem Lab Med. 2007;45(9):1229–1231. doi:10.1515/CCLM.2007.26517635080
   PubMed Web of Science ®Google Scholar
• Smith GD, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med. 2007;4(12):e352. doi:10.1371/journal.pmed.004035218076282
   PubMed Web of Science ®Google Scholar
• Salokangas RK, Honkonen T, Stengard E, Koivisto AM, Hietala J. Cigarette smoking in long-term schizophrenia. Eur Psychiatry. 2006;21(4):219–223. doi:10.1016/j.eurpsy.2005.07.00816360309
   PubMed Web of Science ®Google Scholar
• Haj Mouhamed D, Ezzaher A, Neffati F, Douki W, Gaha L, Najjar MF. Effect of cigarette smoking on plasma uric acid concentrations. Environ Health Prev Med. 2011;16(5):307–312. doi:10.1007/s12199-010-0198-221431788
   PubMedGoogle Scholar
• Gee Teng G, Pan A, Yuan JM, Koh WP. Cigarette smoking and the risk of incident gout in a prospective cohort study. Arthritis Care Res (Hoboken). 2016;68(8):1135–1142. doi:10.1002/acr.2282126714165
   PubMed Web of Science ®Google Scholar
• Keller JN, Kindy MS, Holtsberg FW, et al. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci. 1998;18(2):687–697. doi:10.1523/JNEUROSCI.18-02-00687.19989425011
   PubMed Web of Science ®Google Scholar
• van der Veen RC, Hinton DR, Incardonna F, Hofman FM. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J Neuroimmunol. 1997;77(1):1–7. doi:10.1016/S0165-5728(97)00013-19209262
   PubMed Web of Science ®Google Scholar
• Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J. 1986;235(3):747–754. doi:10.1042/bj23507473753442
   PubMed Web of Science ®Google Scholar
• Xuan J, Pan G, Qiu Y, et al. Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res. 2011;10(12):5433–5443. doi:10.1021/pr200679622007635
   PubMed Web of Science ®Google Scholar